All these findings highlight the significance of FGF19/FGFR4 in treatment resistance phenomenon in breast cancer; thus, more thorough studies are necessary to explore the clinical significance of the FGF19/FGFR4 axis to improve patient outcomes. This evidence concerns the gene FGFR4 and breast cancer.